Virtual Advisory Committees Pose Technical And Practical Challenges For US FDA, Sponsors
Executive Summary
Recent panel review of biologics center's intramural research programs had its share of technical glitches and involved agency speakers blindly presenting to committee members they could not see; the experience suggests the difficulties an industry sponsor with an application hanging in the balance may face if a virtual advisory committee were to be held.
You may also be interested in...
US FDA May Publish Pre-Recorded Presentations Before Virtual Advisory Committee Meetings
The move is intended to streamline virtual advisory committee meetings, FDA official says.
Going Virtual: GSK’s Multiple Myeloma Drug Belantamab Tapped For US FDA Online AdComm In July
Announcement of the 14 July Oncologic Drugs Advisory Committee meeting follows a successful, two-day trial run of the virtual format by the oncology pediatric subcommittee that featured a mix of prerecorded and live sponsor presentations and strict adherence to a call/response approach to ensure orderly conduct.
US FDA May Make Pre-Recorded Virtual Adcom Presentations Available Before Meeting
The move is intended to streamline virtual advisory committee meetings, FDA official says.